These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22338849)

  • 1. Protective compounds in animal models of trigeminal activation and neurodegeneration.
    Vámos E
    Ideggyogy Sz; 2012 Jan; 65(1-2):64-70. PubMed ID: 22338849
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.
    Robotka H; Németh H; Somlai C; Vécsei L; Toldi J
    Eur J Pharmacol; 2005 Apr; 513(1-2):75-80. PubMed ID: 15878711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological effects of some kynurenic acid analogs.
    Nagy K; Plangár I; Tuka B; Gellért L; Varga D; Demeter I; Farkas T; Kis Z; Marosi M; Zádori D; Klivényi P; Fülöp F; Szatmári I; Vécsei L; Toldi J
    Bioorg Med Chem; 2011 Dec; 19(24):7590-6. PubMed ID: 22079867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid.
    Knyihar-Csillik E; Mihaly A; Krisztin-Peva B; Robotka H; Szatmari I; Fulop F; Toldi J; Csillik B; Vecsei L
    Neurosci Res; 2008 Aug; 61(4):429-32. PubMed ID: 18541319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
    Christoph T; Reissmüller E; Schiene K; Englberger W; Chizh BA
    Brain Res; 2005 Jun; 1048(1-2):218-27. PubMed ID: 15922311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.
    Vámos E; Párdutz A; Varga H; Bohár Z; Tajti J; Fülöp F; Toldi J; Vécsei L
    Neuropharmacology; 2009 Sep; 57(4):425-9. PubMed ID: 19580819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid.
    Knyihár-Csillik E; Toldi J; Krisztin-Péva B; Chadaide Z; Németh H; Fenyo R; Vécsei L
    Neurosci Lett; 2007 May; 418(2):122-6. PubMed ID: 17382471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.
    Greco R; Demartini C; Zanaboni AM; Redavide E; Pampalone S; Toldi J; Fülöp F; Blandini F; Nappi G; Sandrini G; Vécsei L; Tassorelli C
    Cephalalgia; 2017 Nov; 37(13):1272-1284. PubMed ID: 27919017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral administration of NR2 antagonists attenuates orofacial formalin-induced nociceptive behavior in rats.
    Park MK; Lee JH; Yang GY; Won KA; Kim MJ; Park YY; Bae YC; Ahn DK
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):982-6. PubMed ID: 21295101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal disease.
    Shaw CA; Bains JS
    Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):127-36. PubMed ID: 11990449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ-produced 7-chlorokynurenate has different effects on evoked responses in rats with limbic epilepsy in comparison to naive controls.
    Zhang DX; Williamson JM; Wu HQ; Schwarcz R; Bertram EH
    Epilepsia; 2005 Nov; 46(11):1708-15. PubMed ID: 16302850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
    Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
    Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex.
    Fejes-Szabó A; Bohár Z; Vámos E; Nagy-Grócz G; Tar L; Veres G; Zádori D; Szentirmai M; Tajti J; Szatmári I; Fülöp F; Toldi J; Párdutz Á; Vécsei L
    J Neural Transm (Vienna); 2014 Jul; 121(7):725-38. PubMed ID: 24385076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
    Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
    Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model.
    Knyihár-Csillik E; Toldi J; Mihály A; Krisztin-Péva B; Chadaide Z; Németh H; Fenyo R; Vécsei L
    J Neural Transm (Vienna); 2007; 114(4):417-21. PubMed ID: 16897600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trigeminal schwannoma presenting as daily migraine headache.
    Helm MR
    Headache; 2004 Oct; 44(9):924. PubMed ID: 15447703
    [No Abstract]   [Full Text] [Related]  

  • 20. The kynurenic acid hypothesis of schizophrenia.
    Erhardt S; Schwieler L; Nilsson L; Linderholm K; Engberg G
    Physiol Behav; 2007 Sep; 92(1-2):203-9. PubMed ID: 17573079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.